Vaccitech
Sue Weatherall has extensive experience in regulatory operations, holding leadership roles at several prominent companies in the biotechnology and pharmaceutical sectors. At Vaccitech, Sue served as Regulatory Operations Manager from July 2022 to August 2024. Prior to that, Sue worked at Orchard Therapeutics as Manager of Regulatory Operations and Submission Manager from November 2021 to June 2022. Sue's experience also includes a position as Senior Manager of Regulatory Operations at Syneos Health from September 2020 to November 2021 and a long tenure at Kinapse as Senior Manager of Regulatory Operations from January 2013 to September 2020. Earlier in Sue's career, a role as Manager of Publishing/Regulatory Operations was held at Mundipharma Research Limited from May 2008 to December 2012.
This person is not in the org chart
This person is not in any offices
Vaccitech
1 followers
Vaccitech is a clinical stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. The company’s proprietary technology platform, comprising Chimpanzee Adenovirus (prime) and MVA (boost) is exceptional at inducing, boosting and maintaining CD8+ and CD4+ T cells, as well as antibodies.